Deborah Schrag is the Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center. She currently holds the George H. Bosl Chair. She is a medical oncologist known for her work in patient care and examination of patient outcomes.
Education and career
Schrag received her undergraduate degree from Harvard University where she studied the history of science. She has an M.D. from Columbia University Medical School and an M.P.H. from Harvard University's School of Public Health. She has worked at Memorial Sloan Kettering Cancer Center and the Dana–Farber Cancer Institute. In 2021 she was named chair of the department of medicine at Memorial Sloan Kettering,[2] and as of 2024 she is the George H. Bosl Chair at Memorial Sloan Kettering Cancer Center.[3]
Research
Schrag is noted for her work in comparing the efficacy of treatments for different forms of cancer. She has examined how the timing of surgery impacts patient outcomes for women with a mutation in a BRCA gene.[4][5] She led a research trial that examined the necessity of radiation therapy for rectal cancer patients.[6][7]
^McLaughlin, Devin; Kunz, Pamela L (June 25, 2023). "Some patients with locally advanced rectal cancer can be spared pelvic radiation". HEM/ONC Today; Thorofare. Vol. 24, no. 9. p. 16 – via Proquest.